HI-TECH PHARMACAL LAUNCHES NEW MARKETING INITIATIVE ON NASAL EAS

e After Favorable Settlement of
Quigley Lawsuit 
Business Editors 
AMITYVILLE, N.Y.--(BUSINESS WIRE)--April 22, 1999--The lawsuit
brought by The Quigley Corporation against Hi-Tech Pharmacal Co.
Inc. (NASDAQ: HITK) charging infringement on their Cold-Eeze mark has
now been dismissed with prejudice. Hi-Tech will have the right to
continue to market and sell its Nasal-Ease products without any
interference from Quigley. 
Commenting on this David Seltzer, president and CEO stated, "I am
pleased with the result in this lawsuit and that we will be able to
continue to sell this unique new product." Nasal Ease is the first
nasal moisturizer that incorporates zinc. 
Seltzer further stated, "We are certain that this product will
start to have the market presence we originally anticipated, before
the Quigley lawsuit.  It will begin to be introduced in some of the
country's largest retail outlets later this year." 
Forward-looking statements (statements which are not historical
facts) in this release are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. 
Investors are cautioned that all forward-looking statements
involve risks and uncertainties, including those risks and
uncertainties detailed in the company's filings with the Securities
and Exchange Commission, copies of which are available from the
company.
 
 
Press spacebar to pause and continue. Press esc to stop.